...
首页> 外文期刊>Journal of clinical neuroscience: official journal of the Neurosurgical Society of Australasia >Matrix metalloproteinase-9 and tissue inhibitor of matrix metalloproteinase-2: Prognostic biological markers in invasive prolactinomas
【24h】

Matrix metalloproteinase-9 and tissue inhibitor of matrix metalloproteinase-2: Prognostic biological markers in invasive prolactinomas

机译:基质金属蛋白酶-9和基质金属蛋白酶-2的组织抑制剂 - 侵袭性催乳素瘤中的预后生物标志物

获取原文
获取原文并翻译 | 示例
           

摘要

In this study, the predictive roles of matrix metalloproteinase (MMP)-9 and tissue inhibitor of matrix metalloproteinase (TIMP)-l and 2 in invasive and noninvasive prolactinomas were examined. Prognostic biomarkers to distinguish between invasive and noninvasive pituitary adenomas are required for the effective treatment of pituitary adenoma patients. We analyzed 57 prolactinoma patients classified as having invasive and noninvasive adenomas for MMP-9, TIMP-1 and TIMP-2 expression using immunohistochemical methods. Significantly higher MMP-9 expression was detected in invasive prolactinomas (p = 0.004). There was also a significant relationship between TIMP-2 expression and invasive behavior (p = 0.004) and TIMP-2 expression and recurrence (p = 0.005). Because MMP-9 expression is significantly increased in invasive prolactinomas, MMP-9 has potential as a marker for invasion. TIMP-2 may be a marker for both invasion and recurrence. These findings require further examination in large scale prospective studies.
机译:在该研究中,研究了基质金属蛋白酶(MMP)-9和基质金属蛋白酶(TIMP)-1和2中的组织抑制剂和2中侵袭性和非侵袭性催乳素瘤中的预测作用。预后生物标志物在垂体腺瘤患者的有效治疗中需要区分侵入性和非侵入性垂体腺瘤。我们分析了57名催乳素瘤患者,分类为使用免疫组化方法对MMP-9,TIMP-1和TIMP-2表达具有侵入性和非侵入性腺瘤。在侵袭性催乳素瘤中检测到显着更高的MMP-9表达(P = 0.004)。 TIMP-2表达和侵入性行为之间也存在显着的关系(P = 0.004)和TIMP-2表达和复发(P = 0.005)。因为侵入式催乳素瘤中MMP-9表达显着增加,所以MMP-9具有作为侵袭的标志物的潜力。 TIMP-2可以是侵袭和复发的标志物。这些调查结果需要进一步检查大规模的前瞻性研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号